Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | SMO | Q99835 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12115793 | 0.80 | HTT (0.44) | ALDH1A1KMT2AGLAHSD17B10MEN1 | |
| SCHEMBL1082850 | 0.78 | CA12 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12169333 | 0.78 | NOTUM (0.49) | RECQLGAAITGB3ITGA2BMAPT | |
| SCHEMBL13355237 | 0.78 | PLA2G1B (0.45) | PLA2G1BATG4BALDH1A1GRM5SMO | |
| SCHEMBL13385734 | 0.78 | RECQL (0.50) | RECQLGAAALDH1A1KMT2ANAMPT | |
| SCHEMBL472267 | 0.77 | RECQL (0.71) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13079622 | 0.76 | GAA (0.47) | GAAALDH1A1KMT2AITGB3ITGA2B | |
| SCHEMBL13385721 | 0.75 | NPC1 (0.53) | GAAALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL12169335 | 0.75 | HPGDS (0.40) | GRM5 | |
| SCHEMBL12169272 | 0.75 | MAPT (0.44) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1546 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4119598-A1 | NANOCOMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | Nanocore ApS (DK) | 2023-01-18 | — | — | EP | claimed |
| US-6391949-B1 | — | — | None | — | — | US | disclosed |
| US-12030851-B2 | Phenol compound, resin composition and method of producing same, and shaped product | ZEON CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| US-12006417-B2 | Additive mixture containing a particular sterically hindered amine compound and a heat reflecting interference pigment | BASF SE (DE) | 2024-06-11 | — | — | US | disclosed |
| US-20240174839-A1 | STABILIZER MIXTURE | BASF SE (DE) | 2024-05-30 | — | — | US | disclosed |
| US-20240175789-A1 | CALIBRATION SLIDES FOR DIGITAL PATHOLOGY | VENTANA MED SYST INC (US) | 2024-05-30 | — | — | US | disclosed |
| US-11981793-B2 | Use of an ultraviolet radiation absorbing composition as a light stabilizer for a shaped artificial polymer article | BASF SE (DE) | 2024-05-14 | — | — | US | disclosed |
| EP-4363373-A1 | CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL LIGANDS | Nanocore ApS (DK) | 2024-05-08 | — | — | EP | disclosed |
| EP-4006092-B1 | PHENOLIC COMPOUND, RESIN COMPOSITION AND METHOD FOR PRODUCING SAME, AND MOLDED BODY | ZEON CORP (JP) | 2024-05-01 | — | — | EP | disclosed |
| WO-2024068415-A1 | CO-STABILIZERS FOR HYDROXYPHENYL TRIAZINE STABILIZED POLYMERS | BASF SE (DE) | 2024-04-04 | — | — | WO | disclosed |
| EP-0299925-A1 | Piperidine-triazine compounds for use as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1989-01-18 | — | — | EP | disclosed |
| EP-0292437-A2 | Piperidylaminotriazine derivatives and their use as stabilizers | CIBA-GEIGY AG (CH) | 1988-11-23 | — | — | EP | disclosed |
| EP-0290393-A2 | Piperidine compounds for use as light stabilizers, heat stabilizers and oxidation stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1988-11-09 | — | — | EP | disclosed |
| EP-0274351-A1 | Substituted 1,3,4-oxathiazol-2-one stabilizers | CIBA-GEIGY AG (CH) | 1988-07-13 | — | — | EP | disclosed |
| EP-0273011-A2 | N,N-bis(hydroxyethyl)hydroxylamine ester stabilizers | CIBA-GEIGY AG (CH) | 1988-06-29 | — | — | EP | disclosed |
| EP-0271446-A1 | Substituted hydroxylamines and compositions stabilized therewith | CIBA-GEIGY AG (CH) | 1988-06-15 | — | — | EP | disclosed |
| EP-0269570-A2 | Compositions stabilized with N-hydroxyiminodiacetic or dipropionic acids or esters thereof | CIBA-GEIGY AG (CH) | 1988-06-01 | — | — | EP | disclosed |
| EP-0263068-A1 | Compositions stabilized with substituted benzylhydroxylamines | CIBA-GEIGY AG (CH) | 1988-04-06 | — | — | EP | disclosed |
| EP-0255990-A2 | Polytriazine compounds containing recurring piperidylamidinotriazine structural units and their use as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1988-02-17 | — | — | EP | disclosed |
| EP-0255478-A1 | Tris(substituted hydroxyphenyl-thio)trithioorthoesters | CIBA-GEIGY AG (CH) | 1988-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030851-B2 | Phenol compound, resin composition and method of producing same, and shaped product | SEM1, RFT1, POLR2A | CA12 3903/4885CA1 3094/4885CA2 3989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.